|
| 37828725 | An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy. | Mol Cancer Ther | 2024 |
| 34601770 | Associations between clinical and histopathological characteristics in oral leukoplakia. | Oral Dis | 2023 |
| 37749621 | The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia. | J Oral Pathol Med | 2023 |
| 37745365 | A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma. | medRxiv | 2023 |
| 37936517 | The value of regular follow-up of oral leukoplakia for early detection of malignant transformation. | Oral Dis | 2023 |
| 35765231 | Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia. | Oral Dis | 2023 |
| 37455307 | MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures. | Biomark Res | 2023 |
| 37432446 | The course of health-related quality of life in the first 2 years after a diagnosis of head and neck cancer: the role of personal, clinical, psychological, physical, social, lifestyle, disease-related, and biological factors. | Support Care Cancer | 2023 |
| 36912284 | Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource. | Int J Cancer | 2023 |
| 36639418 | Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma. | Commun Biol | 2023 |
| 36637878 | <i>In Vitro</i> CRISPR-Cas12a-Based Detection of Cancer-Associated <i>TP53</i> Hotspot Mutations Beyond the crRNA Seed Region. | CRISPR J | 2023 |
| 36796393 | Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. | Lancet Oncol | 2023 |
| 36449687 | Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation. | Clin Cancer Res | 2023 |
| 36069231 | Oral cancer prediction by noninvasive genetic screening. | Int J Cancer | 2023 |
| 36053327 | Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines. | J Cancer Res Clin Oncol | 2023 |
| 34267108 | Age-group-specific trend analyses of oropharyngeal squamous cell carcinoma incidence from 1989 to 2018 and risk factors profile by age-group in 2015-2018: a population-based study in The Netherlands. | Eur J Cancer Prev | 2022 |
| 35406587 | Unmet Needs and Perspectives in Oral Cancer Prevention. | Cancers (Basel) | 2022 |
| 35451620 | Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis. | Virchows Arch | 2022 |
| 36442320 | Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification. | EBioMedicine | 2022 |
| 35973619 | Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer. | Radiother Oncol | 2022 |
| 36055228 | Detection and localization of early- and late-stage cancers using platelet RNA. | Cancer Cell | 2022 |
| 36290836 | Psychoneurological Symptoms and Biomarkers of Stress and Inflammation in Newly Diagnosed Head and Neck Cancer Patients: A Network Analysis. | Curr Oncol | 2022 |
| 35130834 | Secreted protein markers in oral squamous cell carcinoma (OSCC). | Clin Proteomics | 2022 |
| 35065597 | Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer patients and 262 informal caregivers. | BMC Med Res Methodol | 2022 |
| 33107152 | Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project. | Head Neck | 2021 |
| 33634865 | The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma. | Int J Cancer | 2021 |
| 33605260 | [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]. | Ned Tijdschr Tandheelkd | 2021 |
| 35047999 | At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma. | Front Oral Health | 2021 |
| 34738049 | Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma. | JCO Precis Oncol | 2021 |
| 34681717 | NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models. | Int J Mol Sci | 2021 |
| 34071997 | Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization. | Cancers (Basel) | 2021 |
| 34210048 | A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images. | Cancers (Basel) | 2021 |
| 34204886 | Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications. | Cancers (Basel) | 2021 |
| 34311328 | The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis. | Oral Oncol | 2021 |
| 33454834 | The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter? | Support Care Cancer | 2021 |
| 32161279 | Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. | Sci Rep | 2020 |
| 31837430 | Development and Validation of a Novel and Rapid Molecular Detection Method for High-Risk Human Papillomavirus in Formalin-Fixed, Paraffin-Embedded Tumor Tissue. | J Mol Diagn | 2020 |
| 31896811 | Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. | Mod Pathol | 2020 |
| 32047167 | Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition. | Sci Rep | 2020 |
| 31980916 | Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors. | Cancer Immunol Immunother | 2020 |
| 33038723 | Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study. | Oral Oncol | 2020 |
| 32795611 | DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery. | Genomics Proteomics Bioinformatics | 2020 |
| 32590298 | Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients. | Oral Oncol | 2020 |
| 32585557 | Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer. | Oral Oncol | 2020 |
| 32722718 | Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. | PLoS One | 2020 |
| 32442178 | Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. | PLoS One | 2020 |
| 32500196 | Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures. | Eur Radiol | 2020 |
| 32413532 | Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. | Radiother Oncol | 2020 |
| 32167160 | Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma. | Int J Cancer | 2020 |
| 30596895 | ACE: absolute copy number estimation from low-coverage whole-genome sequencing data. | Bioinformatics | 2019 |